Handok-Aventis Deploys Asprova as Core Engine of Supply Chain Management

Share Article

Korean pharmaceutical maker Handok-Aventis started full operation of Japan’s leading advanced planning and scheduling (APS) package Asprova as core engine of its supply chain management initiative in November.

Asprova Corporation announced today that pharmaceutical maker Handok-Aventis of Seoul, South Korea, started operation of the Asprova advanced planning and scheduling (APS) system as core engine of its supply chain management initiative in November.

To secure competitive leadership in the pharmaceutical industry, Handok-Aventis had determined that they would need a revolution that would cast off the habitual practices that they had outgrown. The revolution of choice was the deployment of a supply chain management (SCM) system, which they began investigating seriously in 2004.

They recognized that to make SCM work, they would need to systematize the production planner’s experience and know-how through use of IT and to shorten the planning cycle to rapidly reflect market changes, while creating a state-of-the-art production schedule that maximizes use of limited resources by taking into consideration the capacity of machines and workers. They envisioned the system enabling them to respond rapidly and flexibly to rush orders, order changes, and unexpected situations on the shop floor, while optimizing the factory as a whole.

It was not easy, however, to select a versatile APS system that could reflect the unique requirements of the pharmaceutical manufacturing industry. Handok-Aventis set out on a quest to find the software that fit the bill, thoroughly evaluating four packages, until finally deciding to deploy the Japanese APS system Asprova. Once the system was selected, the shop floor and the system group cooperated closely to prepare the master data and to implement a system for reflecting production results, leading up to the kick-off of actual operation in November.

Handok-Aventis plans to continue its pursuit of excellence in competitive product development, customer satisfaction, and visual management by further strengthening their advanced information infrastructure for transparent management and stable revenue acquisition.

About Handok-Aventis:

Handok-Aventis was established in 1954 and is now one of Korea’s leading pharmaceutical makers, specializing in the manufacture and sale of prescription and nonprescription drugs, medical devices, sanitary articles, cosmetics and industrial chemicals. Learn more at http://www.handok.co.kr/.

About Asprova:

Asprova is an advanced planning and scheduling system that creates high-speed production schedules that link each segment of the factory's supply chain -- sales, manufacturing, and purchasing -- while simultaneously considering the capacities of individual machines and workers. Asprova enables manufacturers to realize visual management by creating high-precision schedules for several months into the future, and facilitates profit increase by shortening lead times, reducing inventory, and increasing on-time deliveries.

Asprova has been deployed in over 1000 factories in Japan, the United States, the United Kingdom, Spain, China, Taiwan, Korea and other countries worldwide and is the leading production scheduler in Japan with a market share of 52.4% (according to Fuji Keizai Co., Ltd.'s "2002 Comprehensive Survey of Market Reality of FA Related Software Packages"). Learn more at http://www.asprova.com/en/home/index.html.

  • Company names and product names mentioned in this press release are trademarks or registered trademarks of their respective companies.


Nathan Scales, Senior Consultant

Asprova Corporation

Tokyo, Japan




Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nathan Scales